Skip to content
CompanyNewsHQ

CompanyNewsHQ

CompanyNewsHQ

  • Industry
    • Accountancy
    • Aerospace & Defense
    • Airline
    • Automotive
    • Chemicals
    • Construction
    • Energy
    • Facilities Management
    • Fashion
    • Finance and Utilities
    • Food and Drink
    • Insurance
    • Legal
    • Logistics
    • M&A News
    • Media & Entertainment
    • Medical Device
    • Parcels
    • Pharmaceutical
    • Private Equity
    • Retail
    • Technology
    • Telecoms
    • Travel
  • Companies A-Z
  • Submit A Press Release
  • Subscribe
  • Advertising
  • Market Analysis
  • Contact Us
Pharmaceutical Company News 

Update on FDA Advisory Committee’s meeting on aducanumab in Alzheimer’s disease

November 7, 2020 Michael Crowe Eisai Co

[unable to retrieve full-text content]


Want to share your news with your industry? Submit a press release.

Post a Press Release


Top 1000 Companies Ranked by Revenue - in Multiple Sectors & Countries.

Browse Top 1000 Lists



More from: Eisai Co | Category: Pharmaceutical Company News
  • ← Full success in Plaine Sud: Eiffage Immobilier & COFFIM deliver nearly 200 sustainable housing units in Clamart Grand Canal

You May Also Like

Committed to increasing access | Novartis

September 16, 2020 Michael Crowe

Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine

September 20, 2020 Michael Crowe

European Commission Approves Two New Regimens of Merck’s KEYTRUDA® (pembrolizumab) as First-Line Treatment for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)

November 20, 2019 Michael Crowe

More Pharmaceutical Company News

  • Update on FDA Advisory Committee’s meeting on aducanumab in Alzheimer’s disease
  • Johnson & Johnson to Host Virtual Medical Devices Update
  • Year-to-date and Q3 2020 results
  • Pfizer Announces Positive Phase 3 Study Results for XELJANZ ® (tofacitinib) in Ankylosing Spondylitis (AS)
  • Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS)
  • Allergan, an AbbVie company, to Share New Data at American Academy of Ophthalmology (AAO) 2020 Virtual
  • Brilinta approved in the US to reduce the risk of stroke in patients with an acute ischaemic stroke or high-risk transient ischaemic attack
  • Forxiga approved in the EU for heart failure
  • RECOVERY Trial Data Monitoring Committee Recommends Continuing Evaluation of REGN-COV2 in All Hospitalized Patients | Regeneron Pharmaceuticals Inc.
  • Lynparza approved in the EU for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
  • Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock
  • Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock
  • Takeda Oncology Demonstrates Leadership in Hematologic Cancers at 62nd American Society of Hematology (ASH) Annual Meeting
  • New clinical and health-related quality of life data in multiple myeloma and rare blood disorders to be presented at ASH 2020
  • Roche to present new data across 16 blood disorders at the American Society of Hematology 2020 Annual Meeting
  • Regeneron Reports Third Quarter 2020 Financial and Operating Results | Regeneron Pharmaceuticals Inc.
  • Regeneron Reports Third Quarter 2020 Financial and Operating Results | Regeneron Pharmaceuticals Inc.
  • AbbVie to Highlight Blood Cancer Leadership and Advancing Oncology Pipeline at the ASH 62ND Annual Meeting
  • Lynparza approved in the EU as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
  • Nov 05,2020 | Chugai Contributes Fourteen Thousand Tons of CO2 Emission Reduction Credits to Tokyo Metropolitan Government | News | CHUGAI PHARMACEUTICAL CO., LTD.
  • Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) as First and Only CFTR Modulator to Treat Eligible Infants With Cystic Fibrosis as Early as Four Months of Age | Vertex Pharmaceuticals
  • Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
  • Amgen To Present At The 29th Annual Credit Suisse Healthcare Conference
  • Need for new heart disease medicines drives wave of potential therapies | Novartis
  • Caelum and Alexion Announce Upcoming Data Presentations at the 62nd American Society of Hematology Annual Meeting and Exposition

About

Company News HQ is a global business news portal. It is the leading industry news source for major companies across a number of industry verticals.

Links

  • Advertising
  • News Tracking Service
  • Submit News
  • Subscribe
  • Contact Us
Copyright © 2020 CompanyNewsHQ. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

  • Industry
    ▼
    • Accountancy
    • Aerospace & Defense
    • Airline
    • Automotive
    • Chemicals
    • Construction
    • Energy
    • Facilities Management
    • Fashion
    • Finance and Utilities
    • Food and Drink
    • Insurance
    • Legal
    • Logistics
    • M&A News
    • Media & Entertainment
    • Medical Device
    • Parcels
    • Pharmaceutical
    • Private Equity
    • Retail
    • Technology
    • Telecoms
    • Travel
  • Companies A-Z
  • Submit A Press Release
  • Subscribe
  • Advertising
  • Market Analysis
  • Contact Us